Pure Global AI
NCT06407388Recruiting

Ultrasound Findings in Diabetic Pregnancies

Ultrasound Findings Predictive of Neonatal Outcomes in Diabetic Pregnancies
Eastern Virginia Medical SchoolClinicalTrials.gov
Verified
Study focus
Disease/Condition
Diabetes
Study type
Observational
Sponsor & location
Primary sponsor
Eastern Virginia Medical School
Location
Norfolk, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2023
End date
Jun 01, 2025
Enrollment
156 participants
Primary outcome

Elevated TcB

Summary

The goal of our study is to identify ultrasonographic markers that can predict adverse
 neonatal outcomes. Specifically, we hypothesize that an increase in fetal liver volumes will
 increase transcutaneous bilirubin (TcB) in the newborn and thus jaundice requiring
 phototherapy. This information can be used in patient counseling and to guide future
 screening protocols for ultrasound in individuals with diabetes.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06407388
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06407388 through Pure Global AI's free database. This phase not specified trial is sponsored by Eastern Virginia Medical School and is currently Recruiting. The study focuses on Diabetes. Target enrollment is 156 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.